Latest Insurance News

Page 6 of 67
IAG has offered a package of competition remedies to support approval of its proposed 20-year insurance alliance with RAC of Western Australia, including the transfer of NRMA policy renewal rights and a $20 million community investment. The insurer says the transaction still carries $1.2 billion in additional annual gross written premium and approximately $100 million in annual pre-tax synergies once integration is complete.
Victor Sage
Victor Sage
14 Oct 2026
WhiteHawk has completed its Quixxi acquisition after shareholders approved every resolution with more than 95% of non-associated votes. The deal adds AI governance, mobile application security and an international customer base, but execution now matters more than the strategic pitch.
Victor Sage
Victor Sage
12 Oct 2026
Emyria’s FY26 annual report shows a rapidly expanding psychedelic-assisted care network, with revenue up 210% and treatment capacity reaching 18 beds across four states. The gains came alongside a larger loss, $4.6 million in operating cash outflow and an auditor-highlighted material uncertainty over the company’s ability to continue without further funding.
Victor Sage
Victor Sage
9 Oct 2026
City Chic Collective lifted FY26 underlying EBITDA 92% to $12.3 million despite a 3.1% revenue decline, helped by stronger ANZ trading, higher margins and a leaner cost base. The retailer remains loss-making after tax, but enters FY27 with $5.2 million in net cash and early signs of renewed store momentum.
Victor Sage
Victor Sage
9 Oct 2026
Australian Ethical Investment delivered record funds under management and a 29% rise in shareholder profit in FY26, despite weak performance from Australian equities and emerging companies. The ASX-listed ethical fund manager also increased its fully franked dividend and set out a growth plan centred on private markets, superannuation and technology.
Claire Turing
Claire Turing
9 Oct 2026
Cynata Therapeutics has launched a fully underwritten $913,000 entitlement offer as it reassesses the future of its Cymerus platform after two major trials failed to demonstrate efficacy. The raise provides short-term funding, but the prospectus warns that further capital may be needed and repeats a material uncertainty over going concern.
Ada Torres
Ada Torres
8 Oct 2026
Kingsgate Consolidated has converted a full year of Chatree mining into record financial results, with revenue up 77% and net profit reaching A$277.9 million. The balance sheet is stronger, dividends have returned and Nueva Esperanza is moving towards a feasibility decision, but higher waste movement and project execution now replace the turnaround story.
Maxwell Dee
Maxwell Dee
7 Oct 2026
An independent, Rhythm-funded economic model estimates its ColoSTAT blood test could avoid 29,427 public-hospital colonoscopies a year and deliver $72.4 million in net annual hospital savings. The figures strengthen Rhythm’s planned case for Medicare reimbursement, but remain modelled estimates rather than evidence from real-world use.
Ada Torres
Ada Torres
7 Oct 2026
hipages Group delivered stronger FY26 cash generation, expanded into insurance and set higher targets for revenue, margins and free cash flow in FY27. The headline profit surge was substantially helped by an $8.9 million deferred tax benefit, making cash flow and platform adoption the more useful measures of progress.
Sophie Babbage
Sophie Babbage
7 Oct 2026
Nuix has returned to statutory profit and generated substantially more cash in FY26, while its Nuix Neo platform became the main engine of growth. The annual report also flags a planned $5 million restructuring, an undisclosed insurance provision and unresolved litigation risks.
Sophie Babbage
Sophie Babbage
6 Oct 2026
Tower has lifted its FY26 underlying NPAT guidance to $69 million-$79 million after large event claims came in below the allowance built into its forecast. Customer growth also remained strong, although customer remediation costs will continue to weigh on reported profit.
Victor Sage
Victor Sage
6 Oct 2026
Steadfast Group has disclosed a notice from Pentwater Capital Management concerning equity derivatives under Takeovers Panel guidance. The filing does not reveal the position’s size, direction, counterparties or economic exposure, leaving its significance unresolved.
Claire Turing
Claire Turing
2 Oct 2026

Browse the archive

Full archive